Previsioni di mercato delle terapie per il cancro al seno in Medio Oriente e Africa fino al 2030 - Analisi regionale - per terapia farmacologica [terapia farmacologica mirata (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab e altre terapie farmacologiche target), terapia farmacologica ormonale (modulatori selettivi del recettore degli estrogeni, Inibitori dell\'aromatasi e downregolatori selettivi del recettore degli estrogeni), chemioterapia e immunoterapia/terapia biologica], tipo di cancro al seno (recettore ormonale, HER2+ e cancro al seno triplo negativo) e canale di distribuzione (farmacie ospedaliere, farmacie e farmacie al dettaglio, e farmacie online)
Il crescente peso del cancro al seno alimenta il mercato terapeutico del cancro al seno in Medio Oriente e Africa.
Il cancro al seno è considerato il cancro al seno più comune cancro tra le donne in tutto il mondo e la sua incidenza è in aumento a livello globale. Fattori come cambiamenti nello stile di vita, squilibri ormonali, predisposizione genetica e fattori ambientali contribuiscono alla crescente prevalenza del cancro al seno. Secondo l’OMS, nel 2020, 685.000 persone sono morte in tutto il mondo a causa del cancro al seno, per un totale di 2,3 milioni di nuove diagnosi. Il cancro al seno è uno dei tumori più comuni a livello globale, con 7,8 milioni di donne vive alla fine del 2020 che avevano ricevuto una diagnosi nei cinque anni precedenti. In tutto il mondo, il cancro al seno colpisce le donne a qualsiasi età dopo l’adolescenza. Tuttavia, la sua prevalenza aumenta con l’età. Con l’aumento dei casi di cancro al seno, c’è una crescente necessità di terapie efficaci e mirate per migliorare i risultati dei pazienti. Ciò ha portato a un aumento delle attività di ricerca e sviluppo nelle terapie per il cancro al seno. Pertanto, il crescente peso del cancro al seno guida il mercato delle terapie per il cancro al seno in Medio Oriente e Africa.
Panoramica del mercato delle terapie per il cancro al seno in Medio Oriente e Africa
Il mercato delle terapie per il cancro al seno in Medio Oriente e Africa è segmentato in Emirati Arabi Uniti, Arabia Saudita, Sud Africa e resto del Medio Oriente e Africa. Il cambiamento delle infrastrutture sanitarie e i partenariati pubblico-privato tra governo e attori internazionali stanno rafforzando il settore sanitario nel paese. Queste partnership e gli sforzi di privatizzazione sono in linea con le politiche incluse nella strategia “Vision 2030” del governo saudita per trasformare l’economia nazionale. Secondo l’Amministrazione del commercio internazionale, il governo dell’Arabia Saudita ha investito circa 65 miliardi di dollari per costruire le infrastrutture sanitarie del paese nell’ambito della Vision 2030. Inoltre, intende aumentare il contributo del settore privato dal 40% al 65% entro il 2030, con un concentrarsi sulla privatizzazione di 290 ospedali e 2.300 centri sanitari primari. Si prevede che maggiori investimenti in infrastrutture e innovazione incoraggeranno la crescita del mercato.
Nel giugno 2023, MSD GCC ha ampliato la sua partnership di ricerca oncologica con il Dipartimento della Salute di Abu Dhabi (DoH). L\'accordo, firmato in occasione della BIO International Convention 2023, ha significato la continuazione di una collaborazione a lungo termine tra le due entità. Nell’ambito della rinnovata partnership, le due parti collaboreranno per avviare due studi di ricerca osservazionali nel campo dell’oncologia, concentrandosi sul cancro del polmone non a piccole cellule e sul cancro al seno triplo negativo. Gli studi mirano a migliorare la capacità di affrontare le sfide sanitarie associate a queste malattie e a migliorare i risultati per i pazienti. Pertanto, i crescenti sforzi delle aziende per diffondere la consapevolezza e lo sviluppo di prodotti nuovi e innovativi nel paese contribuiscono in modo significativo alla crescita del mercato delle terapie per il cancro al seno negli Emirati Arabi Uniti.
Nell\'ottobre 2021, la Banca nazionale del Kuwait (NBK) ha lanciato una campagna annuale per promuovere la salute delle donne durante il mese di sensibilizzazione sul cancro al seno. La campagna fa parte della campagna in corso della Banca per aumentare la consapevolezza sociale riguardo al cancro al seno e promuovere le sue modalità di prevenzione. Pertanto, i fattori sopra menzionati alimentano in modo significativo la crescita del mercato delle terapie per il cancro al seno.
Entrate e previsioni del mercato terapeutico per il cancro al seno in Medio Oriente e Africa fino al 2030 (milioni di dollari)
Segmentazione del mercato terapeutico per il cancro al seno in Medio Oriente e Africa
Medio Oriente e Africa Il mercato delle terapie per il cancro al seno è segmentato in base alla terapia farmacologica, al tipo di cancro al seno e al canale di distribuzione.
Sulla base della terapia farmacologica, il mercato delle terapie per il cancro al seno in Medio Oriente e Africa è segmentato in terapia farmacologica mirata, terapia farmacologica ormonale, chemioterapia e immunoterapia/terapia biologica. Il segmento della terapia farmacologica mirata ha detenuto una quota maggiore nel 2022. Il segmento della terapia farmacologica mirata ha detenuto una quota maggiore nel 2022. Il segmento della terapia farmacologica mirata è ulteriormente suddiviso in abemaciclib, ado-trastuzumab emtansine, palbociclib, trastuzumab e altre terapie farmacologiche target. Inoltre, il segmento della terapia farmacologica ormonale è classificato in modulatori selettivi dei recettori degli estrogeni, inibitori dell\'aromatasi e downregolatori selettivi dei recettori degli estrogeni.
In termini di tipo di cancro al seno, il mercato delle terapie per il cancro al seno in Medio Oriente e Africa è segmentato in recettore ormonale, HER2+ e cancro al seno triplo negativo. Il segmento dei recettori ormonali ha detenuto una quota maggiore nel 2022.
In base al canale di distribuzione, il mercato delle terapie per il cancro al seno in Medio Oriente e Africa è segmentato in farmacie ospedaliere, farmacie e farmacie al dettaglio e farmacie online. Il segmento delle farmacie ospedaliere ha detenuto una quota maggiore nel 2022.
In base al paese, il mercato delle terapie per il cancro al seno in Medio Oriente e Africa è classificato in Sud Africa, Arabia Saudita, Emirati Arabi Uniti e resto del Medio Oriente e dell\'Africa. L\'Arabia Saudita ha dominato il mercato delle terapie per il cancro al seno in Medio Oriente e Africa nel 2022.
Eli Lilly and Co, Eisai Co Ltd, Novartis AG, AstraZeneca Plc, Pfizer Inc, Gilead Sciences Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd e Amgen Inc sono alcune delle aziende leader che operano nel mercato delle terapie per il cancro al seno in Medio Oriente e Africa.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Breast Cancer Therapeutics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Growing Burden of Breast Cancer
4.1.2 Launch of Several Diagnostics and Screening Programs
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis and Treatment
4.3 Key Market Opportunities
4.3.1 Increased Support from Government and Private Organizations
4.4 Key Future Trends
4.4.1 Increasing Use of Personalized Medicine
4.5 Impact Analysis:
5. Breast Cancer Therapeutics Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy
6.1 Overview
6.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
6.3 Targeted Drug Therapy
6.3.1 Overview
6.3.2 Targeted Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Middle East & Africa Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)
6.4 Hormonal Drug Therapy
6.4.1 Overview
6.4.2 Hormonal Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Middle East & Africa Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)
6.5 Chemotherapy
6.5.1 Overview
6.5.2 Chemotherapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Immunotherapy/ Biological Therapy
6.6.1 Overview
6.6.2 Immunotherapy/ Biological Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type
7.1 Overview
7.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
7.3 Hormone Receptor
7.3.1 Overview
7.3.2 Hormone Receptor: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 HER2+ (human epidermal growth factor receptor 2)
7.4.1 Overview
7.4.2 HER2+: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Triple-Negative Breast Cancer
7.5.1 Overview
7.5.2 Triple-Negative Breast Cancer: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Drug Store and Retail Pharmacies
8.4.1 Overview
8.4.2 Drug Store and Retail Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Breast Cancer Therapeutics Market -Country Analysis
9.1 Middle East & Africa Breast Cancer Therapeutics Market, Revenue and Forecast to 2030
9.1.1 Overview
9.1.2 Middle East & Africa Breast Cancer Therapeutics Market, Breakdown, by Country- Revenue (2022) (US$ Million)
9.1.3 Middle East & Africa Breast Cancer Therapeutics Market, by Countries, 2022 and 2030 (%)
9.1.3.1 Saudi Arabia
9.1.3.1.1 Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.1.2 Saudi Arabia: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.1 Saudi Arabia: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.2.2 Saudi Arabia: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.1.3 Saudi Arabia: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.1.4 Saudi Arabia: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.2 UAE
9.1.3.2.1 UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.2.2 UAE: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.1 UAE: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.2.2 UAE: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.2.3 UAE: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.2.4 UAE: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.3 South Africa
9.1.3.3.1 South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.3.2 South Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.1 South Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.2.2 South Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.3.3 South Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.3.4 South Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.3.4 Rest of Middle East & Africa
9.1.3.4.1 Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
9.1.3.4.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.4.2.1 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.4.2.2 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)
9.1.3.4.3 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)
9.1.3.4.4 Rest of Middle East & Africa: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Breast Cancer Therapeutics Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in Breast Cancer Therapeutics Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Eli Lilly and Co
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Eisai Co Ltd
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Novartis AG
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AstraZeneca Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Gilead Sciences Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck & Co Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Teva Pharmaceutical Industries Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Amgen Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
List of Tables
Table 1. Middle East & Africa Breast Cancer Therapeutics Market Segmentation
Table 2. Middle East & Africa Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 10. UAE Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 11. UAE Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 12. UAE Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. South Africa Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 15. South Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 16. South Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 17. South Africa Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. South Africa Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 24. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market
Table 25. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market
Table 26. Glossary of Terms, Breast Cancer Therapeutics Market
List of Figures
Figure 1. Middle East & Africa Breast Cancer Therapeutics Market Segmentation, By Country
Figure 2. Middle East & Africa Breast Cancer Therapeutics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)
Figure 6. Targeted Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Hormonal Drug Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Chemotherapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Immunotherapy/ Biological Therapy: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)
Figure 11. Hormone Receptor: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. HER2+: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Triple-Negative Breast Cancer: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)
Figure 15. Hospital Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Drug Store and Retail Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Online Pharmacies: Middle East & Africa Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Middle East & Africa Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 19. Middle East & Africa Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)
Figure 20. Saudi Arabia Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. UAE Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. South Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Rest of Middle East & Africa Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Growth Strategies in Breast Cancer Therapeutics Market
1. Eli Lilly and Co
2. Eisai Co Ltd
3. Novartis AG
4. AstraZeneca Plc
5. Pfizer Inc
6. Gilead Sciences Inc
7. Merck & Co Inc
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa breast cancer therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution